Biomedical subjects

James M Balter

Publications and source records attributed to James M Balter.

26 records · Page 2Linked to original sources

PubMed2003

Method for quantifying volumetric lesion change in interval liver CT examinations.

We propose a method of using a relatively low degree of freedom (DOF) warping to accurately measure the interval change of lesions having homogeneous contrast. The setting presented here presupposes the use of interval computed tomography (CT) liver exams. After a 3 x 24 DOF warping of the later examination to match the liver's pose in the earlier exam of the interval pair is performed, the lesion's volume change is estimated using the computed difference volume of the two data sets via a novel method that counts partial volume contributions and is insensitive to slight misregistration. A mathematically generated phantom is used to quantify accuracy in the presence of noise. We also quantify the accuracy of our CT liver registrations using microcoils implanted for chemotherapy. A probabilistic liver atlas is used to support automatic masking and liver-focused registration.

Carcinoma, Hepatocellular↗

PubMed2003

A fluence convolution method to account for respiratory motion in three-dimensional dose calculations of the liver: a Monte Carlo study.

We describe the implementation of a fluence convolution method to account for the influence of superior-inferior (SI) respiratory induced motion on a Monte Carlo-based dose calculation of a tumor located in the liver. This method involves convolving the static fluence map with a function describing the SI motion of the liver-the motion function has been previously derived from measurements of diaphragm movement observed under fluoroscopy. Significant differences are noted between fluence-convolved and static dose distributions in an example clinical treatment plan; hot and cold spots (on the order of 25%) are observed in the fluence-convolved plan at the superior and inferior borders of the liver, respectively. This study illustrates that the fluence convolution method can be incorporated into Monte Carlo dose calculation algorithms to account for some of the effects of patient breathing during radiotherapy treatment planning, thus leading to more accurate dose calculations.

Algorithms↗

PubMed2003

A method for incorporating organ motion due to breathing into 3D dose calculations in the liver: sensitivity to variations in motion.

Organ motion has been previously described using a probability distribution function that depends solely upon the amplitude of motion and the degree of asymmetry in the breathing cycle, and that function has been used with patient specific parameters to correct static dose distributions for patient breathing using a dose convolution method. In this study, the consequences of errors in the selection of those two parameters were evaluated. Patients previously treated using a focal liver dose escalation protocol were selected with tumors located in the superior or inferior portion of the liver. For a fixed degree of asymmetry (amplitude), the amplitude (asymmetry) of motion was varied about its nominal value and the consequences of organ motion on the dose distribution and the (potentially new) prescription dose were evaluated. These comparisons show that small (+/- 3 mm) variations of the amplitude of motion about the nominally measured value may not result in clinically significant changes (< a single fraction change in the prescription dose), however, larger variations (> 5 mm) can lead to significant changes. Assuming from measurement that the patient breathes asymmetrically (spends more time at expiration), variations in the assumed degree of asymmetry rarely lead to clinically significant changes; the most significant cause for concern being when the patient breathing cycle is maximally different from the treatment planning case (e.g., patient assumed to spend more time at expiration, but later breaths symmetrically). The results point out where quality assurance efforts should be concentrated to help assure the validity of the assumptions used to correct the static dose distributions for patient breathing using the convolution method.

Algorithms↗

PubMed2002

Analysis of radiation-induced liver disease using the Lyman NTCP model.

PURPOSE: To describe the dose-volume tolerance for radiation-induced liver disease (RILD) using the Lyman-Kutcher-Burman (LKB) normal tissue complication probability (NTCP) model. METHODS AND MATERIALS: A total of 203 patients treated with conformal liver radiotherapy and concurrent hepatic arterial chemotherapy were prospectively followed for RILD. Normal liver dose-volume histograms and RILD status for these patients were used as input data for determination of LKB model parameters. A complication was defined as Radiation Therapy Oncology Group Grade 3 or higher RILD < o r =4 months after completion of radiotherapy. A maximal likelihood analysis yielded best estimates for the LKB NTCP model parameters for the liver for the entire patient population. A multivariate analysis of the potential factors associated with RILD was also completed, and refined LKB model parameters were obtained for patient subgroups with different risks of RILD. RESULTS: Of 203 patients treated with focal liver irradiation, 19 developed RILD. The LKB NTCP model fit the complication data for the entire group. The "n" parameter was larger than previously described, suggesting a strong volume effect for RILD and a correlation of NTCP with the mean liver dose. No cases of RILD were observed when the mean liver dose was <31 Gy. Multivariate analysis demonstrated that in addition to NTCP and the mean liver dose, a primary hepatobiliary cancer diagnosis (vs. liver metastases), bromodeoxyuridine hepatic artery chemotherapy (vs. fluorodeoxyuridine chemotherapy), and male gender were associated with RILD. For 169 patients treated with fluorodeoxyuridine, the refined LKB model parameters were n = 0.97, m = 0.12, tolerance dose for 50% complication risk for whole organ irradiated uniformly [TD50(1)] = 45.8 Gy for patients with liver metastases, and TD50(1) = 39.8 Gy for patients with primary hepatobiliary cancer. CONCLUSION: These data demonstrate that the liver exhibits a large volume effect for RILD, suggesting that the mean liver dose may be useful in ranking radiation plans. The inclusion of clinical factors, especially the diagnosis of primary hepatobiliary cancer vs. liver metastases, improves the estimation of NTCP over that obtained solely by the use of dose-volume data. These findings should facilitate the application of focal liver irradiation in future clinical trials.

Adult↗

PubMed2002

Daily prostate targeting using implanted radiopaque markers.

PURPOSE: A system has been implemented for daily localization of the prostate through radiographic localization of implanted markers. This report summarizes an initial trial to establish the accuracy of patient setup via this system. METHODS AND MATERIALS: Before radiotherapy, three radiopaque markers are implanted in the prostate periphery. Reference positions are established from CT data. Before treatment, orthogonal radiographs are acquired. Projected marker positions are extracted semiautomatically from the radiographs and aligned to the reference positions. Computer-controlled couch adjustment is performed, followed by acquisition of a second pair of radiographs to verify prostate position. Ten patients (6 prone, 4 supine) participated in a trial of daily positioning. RESULTS: Three hundred seventy-four fractions were treated using this system. Treatment times were on the order of 30 minutes. Initial prostate position errors (sigma) ranged from 3.1 to 5.8 mm left-right, 4.0 to 10.1 mm anterior-posterior, and 2.6 to 9.0 mm inferior-superior in prone patients. Initial position was more reproducible in supine patients, with errors of 2.8 to 5.0 mm left-right, 1.9 to 3.0 mm anterior-posterior, and 2.6 to 5.3 mm inferior-superior. After prostate localization and adjustment, the position errors were reduced to 1.3 to 3.5 mm left-right, 1.7 to 4.2 mm anterior-posterior, and 1.6 to 4.0 mm inferior-superior in prone patients, and 1.2 to 1.8 mm left-right, 0.9 to 1.8 mm anterior-posterior, and 0.8 to 1.5 mm inferior-superior in supine patients. CONCLUSIONS: Daily targeting of the prostate has been shown to be technically feasible. The implemented system provides the ability to significantly reduce treatment margins for most patients with cancer confined to the prostate. The differences in final position accuracy between prone and supine patients suggest variations in intratreatment prostate movement related to mechanisms of patient positioning.

Dose Fractionation, Radiation↗

PubMed2002

Daily targeting of intrahepatic tumors for radiotherapy.

INTRODUCTION: A system has been developed for daily targeting of intrahepatic tumors using a combination of ventilatory immobilization, in-room diagnostic imaging, and on-line setup adjustment. By reducing geometric position uncertainty, as well as organ movement, this system permits reduction of margins and thus potentially higher treatment doses. This paper reports our initial experience treating 8 patients with focal liver tumors using this system. METHODS AND MATERIALS: The system includes diagnostic X-ray tubes mounted on the wall and ceiling of a treatment room, an active matrix flat panel imager, in-room control for image acquisition and setup adjustment, and a ventilatory immobilization system via active breathing control (ABC). Eight patients participated in the study, two using an early prototype ABC unit, and the remaining six with a commercial ABC system and improved setup measurement tools. Treatment margins were reduced, and dose consequently increased because of increased confidence in target position under this protocol. After daily setup via skin marks, orthogonal radiographs were acquired at suspended ventilation. The images were aligned to the CT model using the diaphragm for inferior-superior (IS) alignment, and the skeleton for left-right (LR) and anterior-posterior (AP) alignment. Adjustments were made for positioning errors greater than a threshold (3 or 5 mm). After treatment, retrospective analysis determined the final setup accuracy, as well as the error in initial setup measurement performed before setup adjustment. RESULTS: Two hundred sixty-two treatment fractions were delivered on eight patients, with 171 treatments requiring repositioning. Typical treatment times were 25-30 min. Patients were able to tolerate ABC throughout the course of treatment. Breath holds up to 35 s long were used for treatment. The use of on-line imaging and setup adjustment reduced setup errors (sigma) from 4.0 mm (LR), 6.7 mm (IS), and 3.8 mm (AP) to 2.1 mm (LR), 3.5 mm (IS), and 2.3 mm (AP). Prescribed doses were increased using this system by an average of 5 Gy. CONCLUSIONS: Daily targeting of intrahepatic targets has been demonstrated to be feasible. The potential for reduction in treatment margin and consequential safe dose escalation has been demonstrated, while maintaining reasonable treatment delivery times.

Dose Fractionation, Radiation↗

PubMed2002

Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors.

After radiosurgery of malignant tumors, it can be difficult to discriminate between transient treatment effects, radiation necrosis, and tumor progression on post-treatment imaging. Misinterpretation of an enlarging lesion may lead to inappropriate treatment and contribute to disagreements about treatment efficacy. In an effort to clarify this problem, we reviewed our experience with interpreting post-radiosurgical imaging in patients with malignant primary and secondary brain tumors. We reviewed results of radiosurgery of 30 malignant gliomas and 35 metastatic brain tumors with minimum follow up of 1 year or until death. Of 30 gliomas, 73% were larger a mean of 13 weeks after radiosurgery. Of 35 metatstatic tumors, 22% were larger a mean of 10 weeks after radiosurgery. Eleven had 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) of enlarging lesions. Eight showed increased activity with respect to brain; three decreased activity. Of the eight, six predicted incorrectly based upon the patients' subsequent courses (all alive, mean follow up of 27 months), and two correctly, with the patients dying from the imaged lesions 8 and 13 months later. Of the three with FDG uptake less than brain, one patient was alive with 32 weeks of follow up, and two patients died from the imaged lesion 13 and 21 months later. Radiographic enlargement after radiosurgery is common, especially for gliomas. Physicians caring for these patients should be aware of this phenomenon and be cautious in interpreting post-treatment images. MRI appearance may be useful for metastases. FDG-PET seems unreliable. Further evaluation of Tl-201 and HMPAO SPECT or MRS is warranted.

Adult↗

PubMed2002

A comparison of computer-controlled versus manual on-line patient setup adjustment.

A study was performed to determine the relative advantage of computer-controlled couch movement versus manual repositioning to correct patient setup error measured using an electronic portal imaging device (EPID). Twenty-eight on-line setup adjustment trials of anterior-posterior (AP) pelvic projections were evaluated, with 13 setups corrected by automated couch movement determined by direct feedback from the EPID image alignment tool and 15 setups manually corrected based on the transformation displayed from the same tool. The speed of setup adjustment and accuracy of corrected setup were determined. Computer controlled setup adjustment was determined to be faster (25.4 s versus 101.9 s) and slightly more accurate (1.8 mm versus 2.5 mm error in adjusted setup) than manual correction.

Humans↗